Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Glaukos Corp (NY: GKOS ) 117.42 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, Jul 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Glaukos Corp < Previous 1 2 3 4 5 6 7 Next > Why Are Glaukos Shares Rallying Today? November 03, 2021 Glaukos Corporation (NYSE: GKOS) shares have gained as investors cheer the final physician payment rates and outpatient facility fees issued by the Centers for Medicare... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021 November 03, 2021 Upgrades Benchmark upgraded the previous rating for Devon Energy Corp (NYSE: Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 03, 2021 Gainers Glaukos (NYSE:GKOS) stock increased by 25.55% to $56.58 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6 billion... Via Benzinga Why Glaukos Shares Dipped Today July 20, 2021 Glaukos (NYSE:GKOS) shares are trading lower after Wells Far... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday November 03, 2021 Good morning, trader! We're starting the day off right with a dive into the biggest pre-market stock movers for Wednesday! Via InvestorPlace 25 Stocks Moving in Wednesday's Pre-Market Session November 03, 2021 Gainers Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 56.4% to $26.20 in pre-market trading on the heels of three new announcements from the company outlining strategic plans to... Via Benzinga Glaukos Corporation to Release Third Quarter 2021 Financial Results after Market Close on November 4 October 14, 2021 From Glaukos Corporation Via Business Wire The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology October 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:... Via Benzinga Exposures COVID-19 Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 European Society of Cataract and Refractive Surgeons Annual Meeting October 07, 2021 From Glaukos Corporation Via Business Wire Glaukos Announces Licensing Agreement with Attillaps Holdings, Inc. September 20, 2021 From Glaukos Corporation Via Business Wire Ivantis To Pay $60M In Patent Litigation Settlement With Glaukos September 15, 2021 Glaukos Corp (NYSE:GKOS) has Via Benzinga Topics Intellectual Property Exposures Intellectual Property Glaukos Announces Settlement of Patent Litigation with Ivantis, Inc. September 15, 2021 From Glaukos Corporation Via Business Wire The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results October 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... Via Benzinga The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout October 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... Via Benzinga Glaukos Files Pre-Market Application For Intraocular Pressure Device September 03, 2021 Glaukos Corp (NYSE: GKOS) has submitted a supplemental premarket approval (PMA) application to the FDA for its iStent infinite Trabecular Micro-Bypass System.... Via Benzinga Exposures Product Safety Glaukos Announces Submission of Supplemental Pre-Market Approval Application for iStent infinite™ September 03, 2021 From Glaukos Corporation Via Business Wire Return on Capital Employed Overview: Glaukos September 01, 2021 Pulled from Benzinga Pro data Glaukos (NYSE:GKOS) reported Q2 sales of $78.09 million. Earnings fell to a loss of $14.22 million, resulting in a 20.47% decrease from last quarter... Via Benzinga Glaukos Announces Participation in the Wells Fargo Healthcare Conference August 26, 2021 From Glaukos Corporation Via Business Wire Glaukos Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on iStent® Technologies August 23, 2021 From Glaukos Corporation Via Business Wire Glaukos Guided Below Consensus After Q2 Earnings; Analysts Cut Price Target August 06, 2021 Glaukos Corporation (NYSE:GKOS) Via Benzinga Glaukos Corp (GKOS) Q2 2021 Earnings Call Transcript August 06, 2021 GKOS earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Glaukos Corporation Announces Second Quarter 2021 Financial Results August 05, 2021 From Glaukos Corporation Via Business Wire Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Society of Cataract and Refractive Surgery Annual Meeting July 22, 2021 From Glaukos Corporation Via Business Wire Why Glaukos Stock Sank Today July 20, 2021 An analyst downgraded the healthcare stock. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2021 July 26, 2021 Upgrades Tudor Pickering upgraded the previous rating for Precision Drilling Corp (NYSE: Via Benzinga 62 Biggest Movers From Yesterday July 21, 2021 Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment... Via Benzinga Exposures Product Safety Wells Fargo Downgrades Glaukos To Sell On iStent Reimbursement Cuts July 20, 2021 Wells Fargo analyst Lawrence Biegelsen downgraded Glaukos to Underweight from Equal Weight with a price target of $41, down from $100. Via Talk Markets Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021 July 20, 2021 Upgrades For Bank of Marin Bancorp (NASDAQ: Via Benzinga Glaukos Corporation to Release Second Quarter 2021 Financial Results after Market Close on August 5 July 15, 2021 From Glaukos Corporation Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.